GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (STU:ON4) » Definitions » Equity-to-Asset

Ono Pharmaceutical Co (STU:ON4) Equity-to-Asset : 0.75 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Ono Pharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ono Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €4,932 Mil. Ono Pharmaceutical Co's Total Assets for the quarter that ended in Sep. 2024 was €6,595 Mil. Therefore, Ono Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.75.

The historical rank and industry rank for Ono Pharmaceutical Co's Equity-to-Asset or its related term are showing as below:

STU:ON4' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.75   Med: 0.87   Max: 0.91
Current: 0.75

During the past 13 years, the highest Equity to Asset Ratio of Ono Pharmaceutical Co was 0.91. The lowest was 0.75. And the median was 0.87.

STU:ON4's Equity-to-Asset is ranked better than
73.73% of 1043 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs STU:ON4: 0.75

Ono Pharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Ono Pharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Equity-to-Asset Chart

Ono Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.85 0.89 0.84 0.87

Ono Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.88 0.87 - 0.75

Competitive Comparison of Ono Pharmaceutical Co's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Equity-to-Asset falls into.



Ono Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ono Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=4869.383/5610.616
=0.87

Ono Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=4931.65/6595.211
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ono Pharmaceutical Co  (STU:ON4) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Ono Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Ono Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a world-wide business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co Headlines

No Headlines